the only *consistency* is the overlap of those *e

the only *consistency* is the overlap of those *embedded crews* that work OTC targets .. including the author of the first hit piece on P2O .. sound familiar

the reality is P2O has 1000s of retail investors .. many of whom have never sold one share .. and the difference from most OTC targets' worked via the vehicle of choice pertains to *volume* .. usually embeds' bringing in the queen bee was enough to get retail to sell out in droves .. that never happened with P2O .. rather NRs' crews washed 2013/s 36M~ volume with 2014/s 36M~ *volume* after P2O was wrested back (2013) .. all while relentlessly compressing the pps .. sound familiar .. it's done by rote when cycle of money is upside down .. and it's why most OTC targets do not survive .. but the key is the volume .. NR needs lots of *volume* in alignment with relentless pps compression .. not less

that is why 2017's *record low YTD* volume of 13.5M~ matters .. it's not rocket science .. but it is math .. it's also why founder's retention of his PTOI shares is significant to many (not all) early investors

as of today (it may change going forward) .. P2O survives for 4 very specific reasons

founders tech in a sector in its ascension as was duly noted via the ACC Executive Summary of October 2014
former BoD's documentation
current CEO's financial initial financial infusion (9.30.13)
and actual retail investors who've long since acknowledged their risk/reward tolerance and remain steadfast in their response .. i.e. *record low volume in alignment with NRs' relentless PPS compression*


it is what it is .. P2O has options .. what comes to pass only mgmt & the BoD .. *know*
but this tech and emerging sector isn't going away .. what will matter is what is filed and what is articulated

if P2O can show measurable progress .. NR has many more days of 100% *markage* ahead of them .. we shall see what comes to pass

4kids